GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aquarius Surgical Technologies Inc (XCNQ:ASTI) » Definitions » Days Sales Outstanding

Aquarius Surgical Technologies (XCNQ:ASTI) Days Sales Outstanding : 128.73 (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Aquarius Surgical Technologies Days Sales Outstanding?

Aquarius Surgical Technologies's average Accounts Receivable for the three months ended in Dec. 2023 was C$0.08 Mil. Aquarius Surgical Technologies's Revenue for the three months ended in Dec. 2023 was C$0.06 Mil. Hence, Aquarius Surgical Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 128.73.

The historical rank and industry rank for Aquarius Surgical Technologies's Days Sales Outstanding or its related term are showing as below:

XCNQ:ASTI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.25   Med: 145.82   Max: 4592.92
Current: 128.1

During the past 13 years, Aquarius Surgical Technologies's highest Days Sales Outstanding was 4592.92. The lowest was 38.25. And the median was 145.82.

XCNQ:ASTI's Days Sales Outstanding is ranked worse than
86.37% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.66 vs XCNQ:ASTI: 128.10

Aquarius Surgical Technologies's Days Sales Outstanding declined from Dec. 2022 (134.54) to Dec. 2023 (128.73).


Aquarius Surgical Technologies Days Sales Outstanding Historical Data

The historical data trend for Aquarius Surgical Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquarius Surgical Technologies Days Sales Outstanding Chart

Aquarius Surgical Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 178.78 38.25 109.56 161.91 145.82

Aquarius Surgical Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.54 167.70 126.54 115.53 128.73

Competitive Comparison of Aquarius Surgical Technologies's Days Sales Outstanding

For the Medical Devices subindustry, Aquarius Surgical Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aquarius Surgical Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Aquarius Surgical Technologies's Days Sales Outstanding falls into.



Aquarius Surgical Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Aquarius Surgical Technologies's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (0.087 + 0.076) / 2 ) / 0.204*365
=0.0815 / 0.204*365
=145.82

Aquarius Surgical Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.086 + 0.072) / 2 ) / 0.056*365 / 4
=0.079 / 0.056*365 / 4
=128.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aquarius Surgical Technologies  (XCNQ:ASTI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Aquarius Surgical Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Aquarius Surgical Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Aquarius Surgical Technologies (XCNQ:ASTI) Business Description

Traded in Other Exchanges
Address
89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. The company derives revenue from the sale of medical devices and fiber-optic delivery devices. Geographically, it has a presence in Canada, the United States, and the Dominican Republic.